Autologous cord blood cell therapy for neonatal hypoxic-ischaemic encephalopathy: a pilot study for feasibility and safety

Autologous cord blood cell therapy for neonatal hypoxic-ischaemic encephalopathy: a pilot study for feasibility and safety

Abstract Neonatal hypoxic-ischaemic encephalopathy (HIE) is a serious condition; many survivors develop neurological impairments, including cerebral palsy and intellectual disability. Preclinical studies show that the systemic administration of umbilical cord blood cells (UCBCs) is beneficial for ne...

Full description

Saved in:
Bibliographic Details
Main Authors: Masahiro Tsuji, Mariko Sawada, Shinichi Watabe, Hiroyuki Sano, Masayo Kanai, Emi Tanaka, Satoshi Ohnishi, Yoshiaki Sato, Hisanori Sobajima, Takashi Hamazaki, Rintaro Mori, Akira Oka, Hiroyuki Ichiba, Masahiro Hayakawa, Satoshi Kusuda, Masanori Tamura, Makoto Nabetani, Haruo Shintaku
Format: Artigo
Language:English
Published: 2020
Online Access:https://doi.org/10.1038/s41598-020-61311-9
https://www.nature.com/articles/s41598-020-61311-9.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-020-61311-9
https://www.nature.com/articles/s41598-020-61311-9.pdf

Similar Items